Iatrogenic immunodeficiency‐associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis

2022 ◽  
Author(s):  
Kate Zha ◽  
Nicholas J. Silvestri
Keyword(s):  
Mycophenolate Mofetil ◽  
Myasthenia Gravis ◽  
Lymphoproliferative Disorder

scholarly journals A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil

2018 ◽  
Vol 11 (4) ◽  
pp. 241-244 ◽  
Author(s):  
Amr Hanbali ◽  
Marwan Shaheen ◽  
Feras Alfraih ◽  
Wafa Al-Otaibi ◽  
Riad El Fakih ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
T Cell ◽  
Lymphoproliferative Disorder ◽  
Excellent Response

Mycophenolate mofetil in myasthenia gravis: the unanswered question

2008 ◽  
Vol 9 (14) ◽  
pp. 2545-2551 ◽  
Author(s):  
C Phan ◽  
DB Sanders ◽  
ZA Siddiqi
Keyword(s):  
Mycophenolate Mofetil ◽  
Myasthenia Gravis ◽  
Unanswered Question

Epstein–Barr virus associated CNS lymphoproliferative disorder after long-term immunosuppression

2019 ◽  
pp. practneurol-2019-002356 ◽  
Author(s):  
Andrew Lee ◽  
Leslie R Bridges ◽  
Mark Lloyd ◽  
Robert Barker ◽  
Damian R Wren ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Lymphoproliferative Disorder ◽  
Epstein Barr Virus ◽  
Lymphoproliferative Disorders ◽  
Postmortem Brain ◽  
Barr Virus ◽  
Epstein Barr ◽  
High Index Of Suspicion ◽  
Immunomodulatory Therapies

The incidence of Epstein–Barr virus (EBV)associated lymphoproliferative disorders has increased with greater use of immunomodulatory therapies. We present a woman who developed subacute cognitive decline and unilateral weakness while taking long-term mycophenolate mofetil for granulomatosis with polyangiitis; her postmortem brain histopathology confirmed an EBV-driven lymphoproliferative disorder. Clinicians must have a high index of suspicion for EBV-driven lymphoma in people taking long-term immunosuppression who develop new neurological problems. We review the role of mycophenolate mofetil in EBV-driven lymphoproliferative disorders, and discuss checking EBV status in all patients starting immunosuppression and in older people already taking immunosuppression.

Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: Outcomes in 102 patients

2010 ◽  
Vol 41 (5) ◽  
pp. 593-598 ◽  
Author(s):  
Michael K. Hehir ◽  
Ted M. Burns ◽  
Joshua Alpers ◽  
Mark R. Conaway ◽  
Michael Sawa ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Myasthenia Gravis ◽  
Achr Antibody

Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil

Neurology ◽  
1998 ◽  
Vol 51 (3) ◽  
pp. 912-913 ◽  
Author(s):  
R. A. Hauser ◽  
A. R. Malek ◽  
R. Rosen
Keyword(s):  
Mycophenolate Mofetil ◽  
Myasthenia Gravis ◽  
Successful Treatment
Sign in / Sign up

Export Citation Format

Share Document